Lauren Dembeck, PhD

Researchers sought to determine whether corticosteroids would be an effective treatment for patients with chemotherapy-induced thrombocytopenia.

Patients were randomly assigned (1:1) to receive either 6 cycles of FCR every 28 days or IR for up to 6 years.

Researchers sought to create a prediction model to identify patients with unprovoked venous thromboembolism who are at low risk of recurrence.

Researchers sought to determine whether a low dose of inotuzumab ozogamicin would be safe and effective in patients with relapsed/refractory ALL.

Researchers sought to determine whether there was an association between the presence of clonal hematopoiesis of indeterminate potential and protection from Alzheimer’s disease.

Patients received up to 8 cycles of AZA and up to 3 cycle of DLI with increasing T cell dosages.

Researchers sought to determine whether sutimlimab would be safe and effective in treating patients with cold agglutinin disease.

The study included 203 patients with steroid-resistant acute GVHD who were treated at 10 centers in China between September 2014 and March 2019.

Asthma control as measured by AIRQ may predict 12-month HRQoL, according to research reported at the 2021 ACAAI Annual Scientific Meeting.

A post-hoc analysis of LAVOLTA I and II trials assessed effectiveness of lebrikizumab in patients with uncontrolled asthma and high baseline eosinophils.